rethinkTHC Search
Menu
Study breakdown

Lesser-known cannabinoids showed stronger anti-inflammatory effects when combined with other cannabis plant compounds

ObservationalPreliminary evidence
The takeaway

Testing ten non-psychoactive cannabinoids, researchers found CBDV was the most potent anti-inflammatory, and several cannabinoids showed synergistic effects when combined with polar, non-polar, or terpenoid fractions from the cannabis plant.

Cannabis researchers, people interested in full-spectrum vs. isolate products, and those following minor cannabinoid research.

CBDV most potent; CBG and CBN combinations showed synergy

What the researchers found

All ten tested non-psychoactive phytocannabinoids demonstrated anti-inflammatory effects. CBDV was particularly effective, reducing IL-6, TNF-alpha, and inhibiting NF-kB activation. Acidic cannabinoid forms showed high antioxidant capacity (ORAC) but limited cellular antioxidant activity. Combinations containing CBG or CBN with cannabis plant matrices showed particularly potent synergistic anti-inflammatory effects.

Why it matters

Most cannabis research focuses on CBD and THC, but this study systematically compares ten cannabinoids and shows that lesser-known compounds like CBDV, CBG, and CBN may be more effective for inflammation, especially in combination with other plant compounds.

The numbers in context

Ten non-psychotropic cannabinoids tested. CBDV reduced IL-6, TNF-alpha, and NF-kB. Acidic forms showed high ORAC but no significant cellular antioxidant activity. CBG and CBN combinations with plant matrices showed synergistic anti-inflammatory effects.

How the study worked

Anti-inflammatory effects of ten major non-psychotropic phytocannabinoids were tested in macrophage-differentiated THP-1 cells by measuring pro-inflammatory cytokines (ELISA) and NF-kB activation (luciferase reporter). Antioxidant activity was assessed by ORAC and cellular antioxidant activity assays. Synergy was tested with three cannabis-derived matrices (polar, non-polar, terpenoid).

What this study cannot tell us

In vitro study using cell lines, not human subjects. The synergistic effects observed in cells may not translate to oral consumption. Non-polar and terpenoid matrices are complex mixtures making it difficult to identify specific synergy drivers.

How to read the evidence

Preliminary: in vitro cell culture study testing multiple cannabinoids and combinations.

When this study was published

Published 2026.

The bigger picture

This study provides systematic evidence for the "entourage effect" theory, showing that cannabinoids combined with other cannabis plant fractions can produce effects greater than either alone, supporting the therapeutic potential of full-spectrum preparations.

Questions still open

  • Which specific terpenoids or non-cannabinoid compounds drive the synergy? Would these synergistic effects hold with oral delivery and first-pass metabolism? Could CBDV-enriched preparations be developed for inflammatory bowel conditions?

Common questions

Which cannabinoid is most anti-inflammatory?
In this cell study, CBDV (cannabidivarin) was the most effective, reducing multiple inflammatory markers including IL-6, TNF-alpha, and NF-kB activation.
Is the cannabis entourage effect real?
This study found that combining individual cannabinoids with other cannabis plant fractions produced synergistic anti-inflammatory effects greater than either alone, particularly for CBG and CBN combinations.

Read the original research

Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices.

Journal of ethnopharmacology, 360, 121134

Citation

Strnad, Ondřej; Nejedlý, Tomáš; Svoboda, Petr; Mertlíková-Kaiserová, Helena; Malý, Martin; Malý, Matěj; Stránská, Milena; Viktorová, Jitka. (2026). Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices.. Journal of ethnopharmacology, 360, 121134. https://doi.org/10.1016/j.jep.2025.121134

Explore the wider topic